ITMCTR2100004484招募中未知
Clinical study on treatment of Postmenopausal Syndrome after operation of gynecologic malignant tumor with acupuncture and medicine
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 60（—）
- 性别
- Female
入选标准
- •(1) To select the premenopausal or perimenopausal patients who were diagnosed as gynecologic malignant tumor with bilateral whole-uterus Adnexa by histopathology.
- •(2) post-operative symptoms related to Menopausal Syndrome, including vasomotor symptoms, mainly manifested as hot flashes and sweating; autonomic nervous disorders, such as palpitation, dizziness, insomnia, headache, etc.; psychiatric neurologic symptoms, emotional symptoms such as mood swings, depression, suspicion, and lack of self-control.
- •(3) regular menstrual cycle without associated endocrine system disease.
- •(4) informed consent, willingness to cooperate with the researchers follow-up and truthfully answer the researchers questions.
排除标准
- •(1) Patients who took other hormone drugs or health care products 6 months before or after the operation.
- •(2) patients with contraindications.
- •(3) patients with severe cardiovascular, cerebrovascular, hepatic, renal, hematologic and other systemic diseases.
- •(4) patients with other systemic tumors.
研究者
相似试验
尚未招募
1 期
Clinical study on the treatment of Perimenopausal Insomnia with Yishen Pinggan DecoctioITMCTR2000003635Shanghai Municipal Hospital Traditional Chinese Medicine
招募中
1 期
Clinical study for the treatment of perimenopausal syndrome with the method of rank-side perforation.Perimenopausal syndromeITMCTR1900002376The Third Hospital of Shanxi College of Traditional Chinese Medicine ( Shanxi Provincial Acupuncture and Moxibustion Hospital)
招募中
1 期
A clinical trial on problems during menopauseCTRI/2018/02/012231ational institute of siddha
已完成
2 期
Efficacy of Vayasthapana Gana and Rasayanakalpa Vati on Menopausal syndromeCTRI/2015/07/006044INSTITUTE FOR POST GRADUATE TRAINING AND RESEARCH IN AYURVEDA34
进行中（未招募）
不适用
First- Line Treatment of Postmenopausal Patients with Endocrine Responsive Metastatic Breast Cancer. A Randomized, Multicenter Study Comparing Letrozole Combined with Standard Chemotherapy Vs Letrozole Single Agent. The CELER (= CEsar LEtrozole Randomized phase III) Study - CELER Studyhormone-receptor-positive metastatic breast cancerMedDRA version: 8.0Level: PTClassification code 10055113EUCTR2005-001701-26-ATCESAR Central European Society for550